NOTA:FRA
Novartis AG
€144,00
0,00%
(0,00) 1D
29 Okt., 14:45:42 GMT+1 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for NOTA...
Mkt. cap
327,81 mjd
Avg. vol.
12,00
Volume
0,00
52-wk high
€145,00
52-wk low
€102,50
No. of employees
75 k
Mkt. cap
327,81 mjd
Avg. vol.
12,00
Volume
0,00
52-wk high
€145,00
52-wk low
€102,50
No. of employees
75 k
News stories
From web sources and news partners
Seeking Alpha
·
19 uur gelede
Novartis AG 2026 Q3 - Results - Earnings Call Presentation (NYSE:NVS) 2026-10-29
Yahoo Finance
·
2 dae gelede
Novartis AG (NVS) Stock Forecasts
TradingView
·
2 dae gelede
What Novartis (NVS) Said on Its Q3 Earnings Call
GuruFocus
·
2 dae gelede
Novartis Stocks Gain With Higher Guidance but Weaker Cash Genera
Profile
Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland. Novartis is one of the largest pharmaceutical companies in the world and was the eighth largest by revenue in 2024.
Novartis manufactures the drugs clozapine, diclofenac, carbamazepine, valsartan, imatinib mesylate, cyclosporine, letrozole, methylphenidate, terbinafine, deferasirox, and others.
Novartis was formed in 1996 by the merger of Ciba-Geigy and Sandoz. It was considered the largest corporate merger in history during that time. The pharmaceutical and agrochemical divisions of both companies formed Novartis as an independent entity. The name Novartis was based on the Latin terms, novae artes.
After the merger, other Ciba-Geigy and Sandoz businesses were sold, or, like Ciba Specialty Chemicals, spun off as independent companies. The Sandoz brand disappeared for three years, but was revived in 2003 when Novartis consolidated its generic drugs businesses into a single subsidiary and named it Sandoz. Wikipedia
About Novartis AG
CEOVasant Narasimhan
Employees75,3 k
Founded07 Mrt. 1996
HeadquartersBasel, Basel City, Switserland
SectorPharmaceutical industry
Websitenovartis.com